… Cardiovascular disease (CVD) is the leading cause of death worldwide, accounting for
approximately 18 million deaths in 2017. Coronary artery disease is … and glycosylation patterns of …

… glycosylation has been observed to associate with different diseases, including
cardiovascular diseases (… Most of these observations are related to O-glycosylation, yet N-glycosylation …

… of cardiovascular diseases. The knowledge on glycosylation and its effects could be considered
… markers and might be useful as a therapeutic tool to control cardiovascular diseases. …

… glycosylation contribute to normal cardiovascular function and their roles in cardiovascular
disease… glycosylation on the heart and vascular system, highlighting areas for future research. …

… We measured 76 IgG glycosylation traits in 2970 women (… 10-year atherosclerotic
cardiovascular disease risk score and … 10-year atherosclerotic cardiovascular disease risk score …

… We systematically reviewed prospective cohort studies of glycosylated hemoglobin and
cardiovascular disease in persons with diabetes mellitus. This study was part of a larger project …

… the first comprehensive analysis of IgG N-glycosylation in coronary artery disease (CAD). To
… plasma of subjects with angiographically diagnosed coronary artery disease (CAD+) and …

… cardiovascular diseases have a great impact on patient mortality. Both advanced glycation
end products, the result of non-enzymatic glycation … , a glycosylation reaction that is controlled …

… that IgG N-glycosylation may play a role in cardiometabolic disease etiology, … glycosylation
may alter the risk of incident type 2 diabetes and CVD. Further research into IgG glycosylation …

… glycemic control and preventing cardiovascular disease (CVD), by … glycation of hemoglobin
A1c (HbA1c) and the rather static, inherited nucleic acid sequence in our DNA, glycosylation …